Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
2 hedge funds and large institutions have $4K invested in Cellectar Biosciences, Inc. Series A Warrants in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.03K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$416 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$4.03K | +30,498 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$416 | +3,149 | +4,564% |
|
CLRBZ Hedge Fund Activity: Q3 2020 in Review
2 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q3 2020, worth a combined $4K.
Buyers outnumbered sellers: 1 fund opened new CLRBZ positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.03K.
- 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $4K of Cellectar Biosciences, Inc. Series A Warrants stock for Q3 2020.
- 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q3 2020 was Susquehanna International Group, an estimated $4.03K added.
Based on aggregated 13F filings for Q3 2020.